US Trade Office Signals Growing Drug Counterfeiting Problem
A US Trade Representative report says the number of pharmaceutical products and active pharmaceutical ingredients bearing counterfeit trademarks is a “growing problem” and cites China, India, Indonesia, and Thailand as areas of concern.
You may also be interested in...
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.